FR3134004B1 - Dextrines hyperbranchées pour leur utilisation topique pour la prévention ou le traitement d’au moins un symptôme de l’inflammation cutanée. - Google Patents

Dextrines hyperbranchées pour leur utilisation topique pour la prévention ou le traitement d’au moins un symptôme de l’inflammation cutanée. Download PDF

Info

Publication number
FR3134004B1
FR3134004B1 FR2202905A FR2202905A FR3134004B1 FR 3134004 B1 FR3134004 B1 FR 3134004B1 FR 2202905 A FR2202905 A FR 2202905A FR 2202905 A FR2202905 A FR 2202905A FR 3134004 B1 FR3134004 B1 FR 3134004B1
Authority
FR
France
Prior art keywords
dextrins
hyperbranched
prevention
treatment
symptom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2202905A
Other languages
English (en)
Other versions
FR3134004A1 (fr
Inventor
Géraldine Louvet-Pommier
Léon Mentink
Daniel Wils
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roquette Freres SA
Original Assignee
Roquette Freres SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR2202905A priority Critical patent/FR3134004B1/fr
Application filed by Roquette Freres SA filed Critical Roquette Freres SA
Priority to PCT/EP2023/025145 priority patent/WO2023186353A1/fr
Priority to JP2024555253A priority patent/JP2025510664A/ja
Priority to CN202380031776.7A priority patent/CN118973550A/zh
Priority to US18/852,831 priority patent/US20260041703A1/en
Priority to EP23716766.3A priority patent/EP4499034A1/fr
Priority to KR1020247033149A priority patent/KR20240165966A/ko
Publication of FR3134004A1 publication Critical patent/FR3134004A1/fr
Application granted granted Critical
Publication of FR3134004B1 publication Critical patent/FR3134004B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
    • C08B30/12—Degraded, destructured or non-chemically modified starch, e.g. mechanically, enzymatically or by irradiation; Bleaching of starch
    • C08B30/18—Dextrin, e.g. yellow canari, white dextrin, amylodextrin or maltodextrin; Methods of depolymerisation, e.g. by irradiation or mechanically
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention a pour objet des dextrines hyperbranchées, préférentiellement des dextrines hyperbranchées et hydrogénées pour leur utilisation topique pour la prévention ou le traitement d’au moins un symptôme choisi parmi la rougeur, la chaleur, le gonflement et la douleur, ainsi que pour la prévention ou le traitement des symptômes de l’inflammation cutanée et de l’inflammation des muqueuses. Elle a également pour objet l’utilisation de ces dextrines hyperbranchées, et préférentiellement hyperbranchées et hydrogénées pour prévenir ou diminuer ou supprimer l’effet irritant induit par des ingrédients contenus dans des compositions cosmétique ou dermatologique.
FR2202905A 2022-03-30 2022-03-30 Dextrines hyperbranchées pour leur utilisation topique pour la prévention ou le traitement d’au moins un symptôme de l’inflammation cutanée. Active FR3134004B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR2202905A FR3134004B1 (fr) 2022-03-30 2022-03-30 Dextrines hyperbranchées pour leur utilisation topique pour la prévention ou le traitement d’au moins un symptôme de l’inflammation cutanée.
JP2024555253A JP2025510664A (ja) 2022-03-30 2023-03-30 皮膚炎症の少なくとも１つの症状の予防又は治療における局所使用のための超分岐デキストリン
CN202380031776.7A CN118973550A (zh) 2022-03-30 2023-03-30 用于局部使用以预防或治疗至少一种皮肤炎症症状的超支化糊精
US18/852,831 US20260041703A1 (en) 2022-03-30 2023-03-30 Hyperbranched dextrins for topical use in the prevention or treatment of at least one symptom of skin inflammation
PCT/EP2023/025145 WO2023186353A1 (fr) 2022-03-30 2023-03-30 Dextrines hyperbranchees pour leur utilisation topique pour la prevention ou le traitement d'au moins un symptome de l'inflammation cutanee
EP23716766.3A EP4499034A1 (fr) 2022-03-30 2023-03-30 Dextrines hyperbranchees pour leur utilisation topique pour la prevention ou le traitement d'au moins un symptome de l'inflammation cutanee
KR1020247033149A KR20240165966A (ko) 2022-03-30 2023-03-30 피부 염증의 적어도 하나의 증상의 예방 또는 치료에 국소적으로 사용하기 위한 과분지형 덱스트린

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2202905A FR3134004B1 (fr) 2022-03-30 2022-03-30 Dextrines hyperbranchées pour leur utilisation topique pour la prévention ou le traitement d’au moins un symptôme de l’inflammation cutanée.
FR2202905 2022-03-30

Publications (2)

Publication Number Publication Date
FR3134004A1 FR3134004A1 (fr) 2023-10-06
FR3134004B1 true FR3134004B1 (fr) 2025-06-06

Family

ID=82482636

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2202905A Active FR3134004B1 (fr) 2022-03-30 2022-03-30 Dextrines hyperbranchées pour leur utilisation topique pour la prévention ou le traitement d’au moins un symptôme de l’inflammation cutanée.

Country Status (7)

Country Link
US (1) US20260041703A1 (fr)
EP (1) EP4499034A1 (fr)
JP (1) JP2025510664A (fr)
KR (1) KR20240165966A (fr)
CN (1) CN118973550A (fr)
FR (1) FR3134004B1 (fr)
WO (1) WO2023186353A1 (fr)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786775B1 (fr) * 1998-12-04 2001-02-16 Roquette Freres Maltodextrines branchees et leur procede de preparation
US6440432B1 (en) * 1999-03-18 2002-08-27 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Skin cosmetic compositions containing dextran or maltodextrin and a weak carboxylic acid
FR2884422B1 (fr) * 2005-04-18 2008-04-11 Roquette Freres Composition anti-inflammatoire de l'intestin comprenant des maltodextrines branchees
FR2902998B1 (fr) 2006-07-03 2012-09-21 Oreal Utilisation d'au moins un derive c-glycoside a titre d'agent apaisant
FR2918886B1 (fr) 2007-07-17 2010-01-08 Oreal Utilisation d'au moins un extrait bacterien cultive sur eau thermale pour le traitement des peaux, muqueuses et cuirs chevelus sensibles
KR20180036580A (ko) * 2016-09-30 2018-04-09 주식회사 유스바이오팜 수가용화(水加溶化)된 우르소데옥시콜산을 함유하는 염증성 피부질환 또는 중증 소양증 예방 또는 치료용 조성물
FR3093429B1 (fr) * 2019-03-08 2022-06-24 Roquette Freres utilisation de dextrines branchées en soin ou hygiène bucco-dentaire

Also Published As

Publication number Publication date
KR20240165966A (ko) 2024-11-25
JP2025510664A (ja) 2025-04-15
FR3134004A1 (fr) 2023-10-06
EP4499034A1 (fr) 2025-02-05
WO2023186353A1 (fr) 2023-10-05
CN118973550A (zh) 2024-11-15
US20260041703A1 (en) 2026-02-12

Similar Documents

Publication Publication Date Title
CN1275606C (zh) 西蒙得木油的医药用途
Akhoondinasab et al. Assessing effect of three herbal medicines in second and third degree burns in rats and comparison with silver sulfadiazine ointment
US10596148B2 (en) Topical compositions for treatment of psoriasis
Raharivelomanana et al. Tamanu oil and skin active properties: from traditional to modern cosmetic uses
JP2022547922A5 (fr)
MXPA04009755A (es) Composiciones farmaceuticas topicas que comprenden proantocianidinas para el tratamiento de dermatitis.
BRPI0416846B1 (pt) Composições para o tratamento de dermatite atópica, condições alérgicas da pele e acne, e uso.
US9821040B2 (en) Topical therapeutic compositions containing bromelain
PL1988909T3 (pl) Zastosowanie glikolu polietylenowego w miejscowych zaburzeniach lub chorobach związanych z zapaleniem i w gojeniu ran
FR2947727B1 (fr) Composition cosmetique a usage topique, trousse en comportant, procede cosmetique modulable en fonction du vieillissement de la peau la mettant en oeuvre
Awad et al. Stasis dermatitis: pathophysiology, current treatment paradigms, and the use of the flavonoid diosmin
Abdollahi et al. Topical formulation based on arnebia euchroma as a novel possible efficient treatment on epidermolysis bullosa lesions: A case series of fourteen patients
EA200700044A1 (ru) Композиция для местного применения
US10835584B2 (en) Systems for treating dermal inflammatory conditions
FR3130587B3 (fr) Composition comprenant au moins un acide boswellique et/ou au moins un extrait végétal comprenant au moins un acide boswellique pour utilisation topique dans le traitement du vieillissement de la peau
MA33804B1 (fr) Composition pharmaceutique pour le traitement des brûlures cutanées
MX2023012792A (es) Formulaciones topicas que comprenden peroxido de benzoilo y acido azelaico, y uso de los mismos.
FR3133312B1 (fr) Utilisation cosmétique ou dermatologique de Sphingomonas glacialis et/ou d’une composition la comprenant
Ramelet Management of chronic venous disease: the example of Daflon 500 mg
CN103841986B (zh) 应用于皮肤的组合物及其用途
EP2095811A1 (fr) Onguent pour arrêter la chute des cheveux, favoriser leur repousse ainsi que la disparition des taches de vieillesse et des rides, supprimer l'inflammation dans les phlébites et les varices
BE1024364B9 (nl) Samenstelling voor behandeling van perniosis
Raharivelomanana et al. L’huile de Tamanu et ses propriétés dermatologiques: des usages traditionnels à la cosmétique moderne
Hanania et al. Folk medicine/herbal remedies: Topical safflower plant extract for chronic pain: An open-label prospective study
Ruiz et al. Acute Ulceronecrotizing Gingivitis (AUNG) An alternative of treatment with ozonized oil

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20231006

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5